SynAct Pharma — Major Shareholding Notification 2023

Jan 30, 2023

Issuer SynAct Pharma AB

Holder

Nordnet AB (publ)

Instrument

Instrument	Aktie SE0008241491
Before the transaction
Shares	1,473,293
Voting rights	1,473,293
Transaction
Reason for major shareholding notification Share loan
Date	26/01/2023
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	1,482,984
Directly held voting rights	0
Indirectly held voting rights	1,482,984
Percentage
Directly held shares	5.00189 %
Directly held voting rights	0 %
Indirectly held voting rights	5.00189 %

Resulting distribution of total holdings

Shares 5.00189 % 1,482,984 Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 - Physically settled - Cash settled Total 5.00189 % 1,482,984 Chain of controlling companies Voting rights % Voting rights Company 1,455,928 4.91064 Nordnet Pensionsförsäkring AB		Percentage of voting rights:	Number of underlying shares:

27,056	0.09126	Nordnet Livsforsikring AS
Group total holdings
Voting rights		1,482,984
	Percentage of voting rights 5.00189

Notes (other relevant informations according to law)

Nordnet AB (publ) genom Nordnet Pensionsförsäkring AB och Nordnet Livsforsikring AS har överskridit tröskelvärdet 5 % av antalet utestående aktier och röster till följd av retur av aktielån.

Published

30/01/2023 18:54

Contact

Name Rasmus Reivilä

Phone 0704056744 Email rasmus.reivila@nordnet.se

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25